View Poster Contact Presenter Poster Presenter Olamide Shoyinka Authors Olamide Shoyinka Affiliations (1)Drug Discovery Innovation Hub , Ota, Ogun State, Nigeria, (2) Department of Pharmacology and Therapeutics, Olabisi Onabanjo University, Ago- iwoye, Nigeria Part of Topic Good Health and Wellbeing (SDG 3) Browse Topic in full-screen mode Rate Select ratingGive Pharmacophore Screening, Molecular Docking, and ADMET-Based Prioritization of ChEMBL Compounds Targeting the 5-HT1A Receptor for Anxiety Disorders 1/5Give Pharmacophore Screening, Molecular Docking, and ADMET-Based Prioritization of ChEMBL Compounds Targeting the 5-HT1A Receptor for Anxiety Disorders 2/5Give Pharmacophore Screening, Molecular Docking, and ADMET-Based Prioritization of ChEMBL Compounds Targeting the 5-HT1A Receptor for Anxiety Disorders 3/5Give Pharmacophore Screening, Molecular Docking, and ADMET-Based Prioritization of ChEMBL Compounds Targeting the 5-HT1A Receptor for Anxiety Disorders 4/5Give Pharmacophore Screening, Molecular Docking, and ADMET-Based Prioritization of ChEMBL Compounds Targeting the 5-HT1A Receptor for Anxiety Disorders 5/5Cancel rating Average: 5 (6 votes) Share
